Abstract: An autonomous driving device for providing visualized virtual guide information, according to one embodiment of the present invention, includes: an input unit for recognizing and inputting a voice and a motion of an object; a voice analysis unit for analyzing a voice feature value of the object; an image analysis unit for analyzing a motion feature value of the object; a determination unit for defining the meanings of the feature value of the voice and the feature value of the motion, and then determining feedback information corresponding to the defined meanings; and a virtualization unit for outputting guide information about the feedback information by generating or receiving visual information based on augmented reality or virtual reality.

Abstract: A system for providing user-customized information by using an autonomous driving device, includes: an autonomous driving device unit which recognizes at least one user, analyzes specific information of the recognized user, recognizes and analyzes environmental information of the corresponding user, defines contextual information necessary for the corresponding user on the basis of the specific information and the environmental information, and receives customized content information according to the contextual information fed back through Internet and intra network searching, and provides same; and a server unit which is connected to the autonomous driving device unit through the Internet and the intra network, and extracts the customized content information according to the search request from the autonomous driving device unit and feeds back same to the autonomous driving device unit.

Abstract: According to the present invention, an early-phase release amount of cisplatin (CCDP) is reduced and a release of cisplatin is maintained over a long period of time, such that an anticancer effect against cancer cells is enhanced while side effects are reduced. In this manner, a life prolongation effect for patients is enhanced. A microparticle preparation contains cisplatin that is intercalated into double-helical DNA. The microparticle preparation stably retains cisplatin and exhibits an excellent slow-release property. Accordingly, even when cisplatin containing severe toxicity is used, the side effects can be suppressed and an excellent anticancer effect can be provided over a long period of time.